Overview

Clinical Trial Comparing the Efficacy and Safety of DA-3803 and Ovidrel

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy and safety of DA-3803(r-hCG) and Ovidrel for inducting final follicular maturation and early luteinization in women undergoing ovulation induction for assisted reproduction treatment
Phase:
Phase 3
Details
Lead Sponsor:
Dong-A Pharmaceutical Co., Ltd.
Treatments:
Chorionic Gonadotropin